Premium Information is available for this item - Upgrade for $1 a day
6505-01-123-0034
Usp Lidocaine Ointment
6505011230034 011230034 NDC00168-0204-37
January 2023
6
Marketplace 6505-01-123-0034
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-123-0034 5+ Documents (More...)
Ointment6505011230034 011230034 NDC00168-0204-37 Usp Lidocaine Ointment 6505007854357, 6505-00-785-4357Usp
Usp Lidocaine Ointment 6505011230034 NDC00168-0204-37 0THL4 - Sandoz Inc. 114-4681 6505-00-785-
Usp Lidocaine Ointment 6505011230034 NDC00168-0204-37 0THL4 - Sandoz Inc. 114-4681 6505-00-785-
114-4681 6505-00-785-4357 6505-17-112-2612 6505-25-721-0530 6505-01-338-4718 6505-00-174-7127 6505-01-123-0034
Usp Lidocaine Ointment 6505011230034 6505-01-338-4718 6505-00-174-7127 6505-01-123-0034 https//
6505013384718 114-4681 6505-00-785-4357 6505-17-112-2612 Lidocaine Ointment 6505171122612171122612 NDC00168-0204-37
Usp Lidocaine Ointment 6505011230034 0204-37 0THL4 - Sandoz Inc. 114-4681 6505-00-785- https//www.nsnlookup.com
Lidocaine Ointment 6505257210530257210530 Documents 6505-25-721-0530 5+ Documents ( More... ) DAC 4 NDC00168-0204-37
114-4681 6505-00-785-4357 6505-17-112-2612 6505-25-721-0530 6505-01-338-4718 6505-00-174-7127 6505-01-123-0034
Restrictions 6505-01-123-0034
6505-01-123-0034 is a Usp Lidocaine Ointment that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-123-0034
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-123-0034
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-123-0034
- Part Number
- Manufacturer
- Status
- NDC00168-0204-37
- Manufacturer
- 23301 - Fougera Pharmaceuticals Inc. (Active)
- Original Design
- Original Design
Datasheet 6505-01-123-0034
- Characteristic
- Specifications
- FIIG
- Specifications
- A513W0
- Active Ingredient And Strength [CYMG]
- 5.000 Lidocaine Percentage, W/W
- Primary Container Type [CQCT]
- Tube, Collapsible
- Primary Container Content Quantity [CRLK]
- 1.250 Ounces
NATO Stock Numbers Related to 6505-01-123-0034
Freight Information 6505-01-123-0034
6505-01-123-0034 has freight characteristics.. 6505-01-123-0034 has a variance between NMFC and UFC when transported by rail and the description should be consulted.